News

Immunoglobulin adjusted body weight dosing will be the mandated default in BloodSTAR, Australia’s online system for accessing government-funded Ig products. If there is a clinical reason not to use ad...

THANZ Council has been working tirelessly behind the scenes to expand our support for the thrombosis and haemostasis community across our region. A core part of our mission is to foster the next gener...

“COBRRA” Wed 24th June Our first joint THANZ HSANZ webinar ,“COBRRA-Comparison of Bleeding Risk between Rivaroxaban and Apixaban”, will take place on Wednesday 24th June from 6:30-8pm (AES...

The landmark COBRRA (Comparison of Bleeding Risk between Rivaroxaban and Apixaban for acute VTE) trial has been published in the New England Journal of Medicine today. This open-label study, conducted...

As part of the #MyClotStory series, the ISTH’s World Thrombosis Day team has shared this story about Simmi, a young Australian women who suffered multiple massive PEs, subsequent cardiac arrest ...

This year THANZ awarded a S&E Research Grant to Mark Schreuder (Centenary Institute, NSW)Disulfide Bond Modulation of Prothrombin in Antiphospholipid Syndrome

This year THANZ awarded S&E Travel Grants to the following members, to attend ISTH, Washington  Vincent Lu, Julianne Chong, Dianne van der Wal and Jose Perdomo. In addition, Gianna Pastore was als...

As of mid-2024, Australia’s prothrombin complex concentrate (PCC) has been replaced by the new 4-factor PCC (Factors II, VII, IX, X) BERIPLEX P/N (international plasma).  From February 2025, the...

This year THANZ awarded 6 S&E Travel Grants to the following members, who travelled to ISTH, Bangkok  Rowena Brook, Emma Leitinger, Mitchell Moon, Caitlin Rice, Mark Schreuder and Trish Wise ...

This year THANZ awarded S&E Research Grants to the following members Emma Leitinger (Monash Health, Vic)Comparability of anti-Xa assessments using alternate calibration curves in patient...

The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (the C...

The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update pub...

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

This year THANZ awarded S&E Research Grants to the following members Gabriella Pennings (ANZAC Research Institute/Sydney Local Health District)Mechanism/s of acute IL-1β release fro...

This year THANZ awarded 4 S&E Travel Grants to the following members Yvonne Kong who will travel to the University of Pavia, Italy Hannah Stevens will travel to the University of Ca...

The National Blood Authority is pleased to advise that the National Statement for the Emergency Use of Group O Red Blood Cells is now available on the National Blood Authority’s website. The Nati...

You can listen to the ABCs Coronacast podcast from Thursday 3rd June, where THANZ member Tim Brighton speaks to host Norman Swan, here. Tim discusses risk factors, diagnosis, early detection, treatmen...

The THANZ and the Australian Technical Advisory Group on Immunisation (ATAGI)  joint statement on  Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZenecThe stateme...

The multidisciplinary VITT Communication Committee has developed and endorsed a  VITT guideline for doctors. The guideline has also been endorsed by the THANZ VITT Advisory Committee and  we are await...

The National Blood Authority (NBA) has been monitoring the rapidly evolving situation with regard to vaccine-induced immune thrombotic thrombocytopenia (VITT), otherwise known as thrombosis with throm...

The THANZ advisory statement on suspected vaccine induced prothrombotic immune thrombocytopenia (VIPIT) has been developed by the THANZ Vaccine Thrombocytopenia Working Group and i...

The joint statement is available for members-only to download here.

The full statement can be found here and the text is reproduced below. “Following the ATAGI statement of 19 March 2021 on the safety of the AstraZeneca COVID-19 vaccine,...

Venous thromboembolism (VTE) remains among the 20 most frequently occurring hospital acquired complications [1]. The Australian Commission for Quality and Safety in Health Care (ACQSHC) has ...

The National COVID-19 Clinical Evidence Taskforce has today issued guidance on CPR during the pandemic. Healthcare workers and trained first aid responders are being urged not to delay commencing card...

The THANZ Education Committee has developed a patient information leaflet aimed at preventing another clot. The leaflet, which is being launched to coincide with World Thrombosis Day, 13th Octobe...

Emerging research has shown that patients who are hospitalized with COVID-19 have a high risk of  developing a venous thromboembolism or VTE. A  consensus statement has been issued by 7...

The THANZ Clinical Trials Group (CTG) is now accepting applications from THANZ members for grants to support T&H clinical trials. Each year there will be a maximum of $80,000 of grants available. ...

More information about the Clinical Care Standard, which is endorsed by THANZ,  can be found here

The THANZ Education Committee has launched a new series of on-line patient information leaflets covering  Deep Vein Thrombosis Anti thrombin deficiency Factor V Leiden gene mutation Protein C def...

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requireme...

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requireme...

The ANZSBT has released of the Guidelines for the Administration of Blood Products, 3rd Edition, 2018. These guidelines were developed by the Clinical Practice Improvement Committee (CP...

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

The following ASTH members have provided their research topics and availability for supervision. If you’re interested in adding your name to this list please contact [email protected]. Members can also...

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled th...